Cargando…

Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients

BACKGROUND: Effective management of heart failure is complex, and ensuring evidence-based practice presents a major challenge to health services worldwide. Over the past decade, the United Kingdom introduced a series of national initiatives to improve evidence-based heart failure management, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Conrad, Nathalie, Judge, Andrew, Canoy, Dexter, Tran, Jenny, O’Donnell, Johanna, Nazarzadeh, Milad, Salimi-Khorshidi, Gholamreza, Hobbs, F. D. Richard, Cleland, John G., McMurray, John J. V., Rahimi, Kazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528949/
https://www.ncbi.nlm.nih.gov/pubmed/31112552
http://dx.doi.org/10.1371/journal.pmed.1002805
_version_ 1783420307552337920
author Conrad, Nathalie
Judge, Andrew
Canoy, Dexter
Tran, Jenny
O’Donnell, Johanna
Nazarzadeh, Milad
Salimi-Khorshidi, Gholamreza
Hobbs, F. D. Richard
Cleland, John G.
McMurray, John J. V.
Rahimi, Kazem
author_facet Conrad, Nathalie
Judge, Andrew
Canoy, Dexter
Tran, Jenny
O’Donnell, Johanna
Nazarzadeh, Milad
Salimi-Khorshidi, Gholamreza
Hobbs, F. D. Richard
Cleland, John G.
McMurray, John J. V.
Rahimi, Kazem
author_sort Conrad, Nathalie
collection PubMed
description BACKGROUND: Effective management of heart failure is complex, and ensuring evidence-based practice presents a major challenge to health services worldwide. Over the past decade, the United Kingdom introduced a series of national initiatives to improve evidence-based heart failure management, including a landmark pay-for-performance scheme in primary care and a national audit in secondary care started in 2004 and 2007, respectively. Quality improvement efforts have been evaluated within individual clinical settings, but patterns of care across its continuum, although a critical component of chronic disease management, have not been studied. We have designed this study to investigate patients’ trajectories of care around the time of diagnosis and their variation over time by age, sex, and socioeconomic status. METHODS AND FINDINGS: For this retrospective population-based study, we used linked primary and secondary health records from a representative sample of the UK population provided by the Clinical Practice Research Datalink (CPRD). We identified 93,074 individuals newly diagnosed with heart failure between 2002 and 2014, with a mean age of 76.7 years and of which 49% were women. We examined five indicators of care: (i) diagnosis care setting (inpatient or outpatient), (ii) posthospitalisation follow-up in primary care, (iii) diagnostic investigations, (iv) prescription of essential drugs, and (v) drug treatment dose. We used Poisson and linear regression models to calculate category-specific risk ratios (RRs) or adjusted differences and 95% confidence intervals (CIs), adjusting for year of diagnosis, age, sex, region, and socioeconomic status. From 2002 to 2014, indicators of care presented diverging trends. Outpatient diagnoses and follow-up after hospital discharge in primary care declined substantially (ranging from 56% in 2002 to 36% in 2014, RR 0.64 [0.62, 0.67] and 20% to 14%, RR 0.73 [0.65, 0.82], respectively). Primary care referral for diagnostic investigations and appropriate initiation of beta blockers and angiotensin-converting–enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) both increased significantly (37% versus 82%, RR 2.24 [2.15, 2.34] and 18% versus 63%, RR 3.48 [2.72, 4.43], respectively). Yet, the average daily dose prescribed remained below guideline recommendations (42% for ACE-Is or ARBs, 29% for beta blockers in 2014) and was largely unchanged beyond the first 30 days after diagnosis. Despite increasing rates of treatment initiation, the overall dose prescribed to patients in the 12 months following diagnosis improved little over the period of study (adjusted difference for the combined dose of beta blocker and ACE-I or ARB: +6% [+2%, +10%]). Women and patients aged over 75 years presented significant gaps across all five indicators of care. Our study was limited by the available clinical information, which did not include exact left ventricular ejection fraction values, investigations performed during hospital admissions, or information about follow-up in community heart failure clinics. CONCLUSIONS: Management of heart failure patients in the UK presents important shortcomings that affect screening, continuity of care, and medication titration and disproportionally impact women and older people. National reporting and incentive schemes confined to individual clinical settings have been insufficient to identify these gaps and address patients’ long-term care needs.
format Online
Article
Text
id pubmed-6528949
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65289492019-05-31 Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients Conrad, Nathalie Judge, Andrew Canoy, Dexter Tran, Jenny O’Donnell, Johanna Nazarzadeh, Milad Salimi-Khorshidi, Gholamreza Hobbs, F. D. Richard Cleland, John G. McMurray, John J. V. Rahimi, Kazem PLoS Med Research Article BACKGROUND: Effective management of heart failure is complex, and ensuring evidence-based practice presents a major challenge to health services worldwide. Over the past decade, the United Kingdom introduced a series of national initiatives to improve evidence-based heart failure management, including a landmark pay-for-performance scheme in primary care and a national audit in secondary care started in 2004 and 2007, respectively. Quality improvement efforts have been evaluated within individual clinical settings, but patterns of care across its continuum, although a critical component of chronic disease management, have not been studied. We have designed this study to investigate patients’ trajectories of care around the time of diagnosis and their variation over time by age, sex, and socioeconomic status. METHODS AND FINDINGS: For this retrospective population-based study, we used linked primary and secondary health records from a representative sample of the UK population provided by the Clinical Practice Research Datalink (CPRD). We identified 93,074 individuals newly diagnosed with heart failure between 2002 and 2014, with a mean age of 76.7 years and of which 49% were women. We examined five indicators of care: (i) diagnosis care setting (inpatient or outpatient), (ii) posthospitalisation follow-up in primary care, (iii) diagnostic investigations, (iv) prescription of essential drugs, and (v) drug treatment dose. We used Poisson and linear regression models to calculate category-specific risk ratios (RRs) or adjusted differences and 95% confidence intervals (CIs), adjusting for year of diagnosis, age, sex, region, and socioeconomic status. From 2002 to 2014, indicators of care presented diverging trends. Outpatient diagnoses and follow-up after hospital discharge in primary care declined substantially (ranging from 56% in 2002 to 36% in 2014, RR 0.64 [0.62, 0.67] and 20% to 14%, RR 0.73 [0.65, 0.82], respectively). Primary care referral for diagnostic investigations and appropriate initiation of beta blockers and angiotensin-converting–enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) both increased significantly (37% versus 82%, RR 2.24 [2.15, 2.34] and 18% versus 63%, RR 3.48 [2.72, 4.43], respectively). Yet, the average daily dose prescribed remained below guideline recommendations (42% for ACE-Is or ARBs, 29% for beta blockers in 2014) and was largely unchanged beyond the first 30 days after diagnosis. Despite increasing rates of treatment initiation, the overall dose prescribed to patients in the 12 months following diagnosis improved little over the period of study (adjusted difference for the combined dose of beta blocker and ACE-I or ARB: +6% [+2%, +10%]). Women and patients aged over 75 years presented significant gaps across all five indicators of care. Our study was limited by the available clinical information, which did not include exact left ventricular ejection fraction values, investigations performed during hospital admissions, or information about follow-up in community heart failure clinics. CONCLUSIONS: Management of heart failure patients in the UK presents important shortcomings that affect screening, continuity of care, and medication titration and disproportionally impact women and older people. National reporting and incentive schemes confined to individual clinical settings have been insufficient to identify these gaps and address patients’ long-term care needs. Public Library of Science 2019-05-21 /pmc/articles/PMC6528949/ /pubmed/31112552 http://dx.doi.org/10.1371/journal.pmed.1002805 Text en © 2019 Conrad et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Conrad, Nathalie
Judge, Andrew
Canoy, Dexter
Tran, Jenny
O’Donnell, Johanna
Nazarzadeh, Milad
Salimi-Khorshidi, Gholamreza
Hobbs, F. D. Richard
Cleland, John G.
McMurray, John J. V.
Rahimi, Kazem
Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients
title Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients
title_full Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients
title_fullStr Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients
title_full_unstemmed Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients
title_short Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients
title_sort diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: a cohort study of 93,000 uk patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528949/
https://www.ncbi.nlm.nih.gov/pubmed/31112552
http://dx.doi.org/10.1371/journal.pmed.1002805
work_keys_str_mv AT conradnathalie diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT judgeandrew diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT canoydexter diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT tranjenny diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT odonnelljohanna diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT nazarzadehmilad diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT salimikhorshidigholamreza diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT hobbsfdrichard diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT clelandjohng diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT mcmurrayjohnjv diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients
AT rahimikazem diagnostictestsdrugprescriptionsandfollowuppatternsafterincidentheartfailureacohortstudyof93000ukpatients